Clinical Trials in Dallas

Showing 361-380 of 17,468 trials

PREEMIE: Study for Treatment of PDA in Premature Infants

NCT06587282

This multicenter, single arm, prospective, non-randomized study is designed to evaluate the safety and effectiveness of The Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in pre-mature infants over a period of 6 months.

Patent Ductus Arteriosus (PDA)

Merit Medical Systems, Inc.55 participantsStarted Mar 2025

Sacramento, California, United States • San Diego, California, United States • Hollywood, Florida, United States +6 more locations

Active Not RecruitingPhase 3< 1 mile

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

NCT06088290

The primary objective of this phase III study is to evaluate whether the combination of lurbinectedin plus doxorubicin given as first line treatment for metastatic leiomyosarcoma (LMS) prolongs the progression-free survival (PFS) by Independent Review Committee (IRC) when compared to doxorubicin administered as a single agent.

Leiomyosarcoma

PharmaMar455 participantsStarted Sep 2023

Phoenix, Arizona, United States • Beverly Hills, California, United States • Los Angeles, California, United States +94 more locations

PREEMIE: Study for Treatment of PDA in Premature Infants

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

Find Trials by Condition in Dallas

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Remote Game-based Exercise Program for Cognitive and Motor Function Improvement

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)